NAMZARIC
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 22 Oct 2022)
What this means for you
Registered since 23 Aug 2016. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 85967489
- Registration number
- 5027427
- Mark type
- Stylized text
- Filed
- 24 Jun 2013
- Published for opposition
- 12 Nov 2013
- Registered
- 23 Aug 2016
- Attorney of record
- G. Patrick SAGE
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of [ bacterial infections, pain, cardiovascular system diseases and disorders, respiratory system diseases and disorders, ] central nervous system diseases and disorders; [ antidepressants; ] antipsychotics
Owner
- MERZ PHARMA GMBH & CO. KGAA, FRANKFURT AM MAIN, DE
- Forest Laboratories, Inc., Parsippany, NY, US
- Forest Laboratories, Inc., Parsippany, NY, US
- Forest Laboratories, Inc., New York, NY, US
Prosecution history
- 23 Aug 2025 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 22 Oct 2022 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 22 Oct 2022 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 20 Oct 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 21 Apr 2022 — TEAS SECTION 8 & 15 RECEIVED
- 23 Aug 2021 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 28 Sept 2016 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 14 Sept 2016 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 23 Aug 2016 — REGISTERED-PRINCIPAL REGISTER
- 19 Jul 2016 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 18 Jul 2016 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 17 Jul 2016 — STATEMENT OF USE PROCESSING COMPLETE
- 24 Jun 2016 — USE AMENDMENT FILED
- 24 Jun 2016 — TEAS STATEMENT OF USE RECEIVED
- 21 Jan 2016 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED